Kevin DeGeeter

Stock Analyst at Ladenburg Thalmann

(2.66)
# 752
Out of 5,441 analysts
66
Total ratings
Success rate
Average return
43 Stocks
Name Action PT Current % Upside Ratings Updated
ORIC ORIC Pharmaceuticals
Initiates Coverage On: Buy
15
9.19 63.22% 2 Jul 8, 2025
NVCR NovoCure
Initiates Coverage On: Buy
30
10.91 174.98% 4 Jul 8, 2025
ORTX Orchard Therapeutics
Reiterates: Outperform
34
16.7 103.59% 3 Aug 9, 2023
ANTX AN2 Therapeutics
Initiates Coverage On: Outperform
22
1.05 1995.24% 1 Apr 19, 2022
PSNL Personalis
Maintains: Outperform
30 24
4.5 433.33% 4 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
141 125
20.63 505.91% 3 Jan 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
18
2.88 525% 1 Nov 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
19
2.32 718.97% 1 Nov 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 1 Oct 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
600
8.87 6664.37% 1 Sep 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
75 80
168.22 -52.94% 1 Aug 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
161 155
40.92 278.79% 2 Jul 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Jun 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
5.93 321.59% 1 May 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
30
n/a n/a 1 May 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
61200
9.02 678392.24% 1 Apr 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
48
n/a n/a 2 Apr 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
1800
2.79 64416.13% 1 Mar 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Mar 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
120
n/a n/a 1 Jan 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
53
n/a n/a 1 Jan 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Jan 11, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jan 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 4 Dec 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
1500
4.5 33233.33% 1 Jul 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
70 105
n/a n/a 2 Apr 17, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
900
2.9 30934.48% 1 Apr 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
2 17
n/a n/a 1 Jan 16, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
33 0
n/a n/a 1 Jun 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Dec 26, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
n/a n/a 1 Nov 20, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 2 Aug 9, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Aug 4, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
150
n/a n/a 1 Aug 3, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
165
12.96 1173.15% 1 Jun 6, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
225
61.9 263.49% 1 Apr 12, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
n/a
n/a n/a 2 Feb 8, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 2 Jan 4, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Dec 29, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Dec 9, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 1 Oct 4, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Oct 3, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
23 52
n/a n/a 1 Sep 6, 2016